We use cookies to give you the best possible experience. If you continue, we’ll assume you are happy to receive the cookies we place. Privacy and cookies information.
News
-
New immunotherapy trial gives hope to those with asbestos related cancer
12 October 2017
The Royal Marsden has opened a groundbreaking immunotherapy trial called PROMISE-meso, to potentially give a new treatment option for people with relapsed mesothelioma
Read more -
Pioneering ‘precision’ radiotherapy boosts prostate cancer survival
26 September 2017
A high-tech form of radiotherapy can dramatically improve outcomes for patients with prostate cancer, long-term clinical trial results show
Read more -
Major breakthroughs spell hope for melanoma patients
11 September 2017
Researchers have discovered what could be the first ever widely used therapies to prevent melanoma patients relapsing
Read more -
The Royal Marsden pilots new Triggers tool for integrating palliative care
8 September 2017
A new tool to identify patients who would benefit from early palliative care is being presented at the ESMO 2017 Congress
Read more -
Consultants present at ESMO Congress
8 September 2017
World-leading consultants from The Royal Marsden and the ICR are presenting at the annual European Society for Medical Oncology (ESMO) Congress
Read more -
Scientists uncover a deadly ‘addiction’ in oesophageal cancer
23 August 2017
Scientists have discovered a new way of attacking oesophageal cancer cells that could make use of an existing drug in a new approach to treatment
Read more -
Patients survive longer on targeted cancer wonder drug
19 August 2017
A significant minority of patients with advanced and aggressive cancer have survived more than 10 years after treatment with one of the first successful targeted cancer drugs
Read more -
Testing for immune ‘hotspots’ can predict risk that breast cancer will return
4 August 2017
Scientists have developed a new test that can pick out women at high risk of relapsing from breast cancer within 10 years of diagnosis
Read more -
New analysis sheds light on mutations in cancer and the immune system
10 July 2017
A large scale analysis of more than 5,000 tumour samples, covering 19 cancer types, has shed light on how different types of mutations may be seen by the immune system
Read more -
CQC ranks Royal Marsden in top four trusts for inpatient care
13 June 2017
The Royal Marsden is one of the best places in the country to receive care, according to a national inpatient survey.
Read more